4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000813
Chief Executive Officer sold 10,000 shares at $27.98 ($279,750)
- Chief Executive Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mazumdar Claire · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $3.79 | $37,898 | 372,152 | D |
| 2026-08-10 | Sale : show line 2 in the form 10b5-1 | −10,000 | $27.98 | $279,750 | 362,152 | D |
| Open-market sales · 10,000 sh · avg $27.98 · $279,750 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 110,546 | D |
Loading xslF345X06/wk-form4_1786565953.xml…